●
Hospital Cytology Labs
Standardised multiplex workflows for routine fluid and FNA cytology.
X-ZELL develops the Cryosuite cryoimmunostaining platform, Cryophore multiplex panels, verified antibodies, and ISO 13485-certified reagents.
Regulatory note: Product availability, regulatory status, and intended use may vary by market. Please contact X-ZELL for current documentation.
Modern cytopathology is constrained by tissue exhaustion: every immunostain consumes a section of the specimen, and by the time the most informative markers are requested, the sample is gone.
Our cryoimmunostaining workflow extracts up to 8 markers from a single cytology slide — preserving the specimen for downstream molecular testing and expanding the picture available to pathologists, oncologists, and their patients.
We are a wet-lab and computational company rebuilding cytopathology from the molecular chemistry up — designed for cytology specimens, manufactured under ISO 13485 in Thailand, and built for the OEM, distribution, and diagnostic partners that serve South-East Asia and beyond.
Standardised multiplex workflows for routine fluid and FNA cytology.
Centralised panel design and reagent supply across multi-site networks.
Tender-ready Cryophore panels and reagent supply for SEA markets.
OEM and private-label manufacturing for IVD developers.
RUO multiplex panels and verified antibodies for translational programmes.
ISO 13485-certified contract manufacturing in Thailand.
Use imagery where it clarifies capability: laboratory preparation, microscope review and quality-controlled workflow execution.
Hands-on cytology preparation and cryoimmunostaining workflow development.
Hybrid microscopy and multi-channel image interpretation support.
Documentation, screening and customer-facing technical collaboration.
Awards are used as trust signals, not as substitutes for product-specific regulatory documentation or clinical evidence.
